Skip to main content
Caplight Logo









Tempo Therapeutics, Inc.

Tempo Therapeutics, Inc.

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://www.tempothera.com/

Last Round

Series B

Sep 11, 2026

Total Funding Raised

$14.3M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Tempo Therapeutics, Inc. is a biotechnology company developing synthetic biomaterials for use in a variety of surgical reconstruction and therapeutic regenerative applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Advanced Materials, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

regenerative medicinebiomaterialstissue engineeringmicroporous annealed particleMAP technologyinjectable scaffoldssoft tissue reconstructionwound carebiosurgerybiotechtissue repairantigen deliveryclinical-stage biotechmedtechbioprinting

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Tempo Therapeutics, Inc. Comparables

Compare Tempo Therapeutics, Inc. with similar companies based on industry and business-model similarity.

Tempo Therapeutics, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
inSoma Bio
82%
BioMimir Inc.
79%
4Tissue
78%

Tempo Therapeutics, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BSep 11, 2026
AcceleratorJun 5, 2025
Series AMar 19, 2024
GrantNov 17, 2020

Key People

Founding team and executive leadership

Westbrook Weaver

Founder And CEO

Founding Team

Tempo Therapeutics, Inc. Investors

Notable investors and investment history

Tempo Therapeutics, Inc. investors
InvestorRounds
Mesa Verde Venture PartnersSeries B
MedTech InnovatorAccelerator
NIH RADxGrant
YK BioventuresSeries A, Series B
AJAX Capital PartnersSeries A
Gideon Strategic PartnersSeries B
National Institutes of Health (NIH)Grant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 11, 2026

    $14M raised in early funding.

  • Jun 20, 2026

    Monthly visitors increased 230% MoM, reaching 5.5K.

Recent news

Latest coverage and updates

  • receives_financingSep 23, 2026

    Tempo Therapeutics received financing of $2.25M in NIH SBIR grant on Sep 23rd '26.

Tempo Therapeutics, Inc. Filings

Explore SEC and related filing metadata, where available.

Tempo Therapeutics, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Firmographic Details

HeadquartersSan Diego, California
Employee Range11
Year Founded2014
Last FundingSep 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?